A randomized controlled pilot study to evaluate the effect of an enteral formulation designed to improve gastrointestinal tolerance in the critically ill patient—the SPIRIT trial
Crossref DOI link: https://doi.org/10.1186/s13054-017-1730-1
Published Online: 2017-06-10
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jakob, Stephan M.
Bütikofer, Lukas
Berger, David
Coslovsky, Michael
Takala, Jukka
Funding for this research was provided by:
Nestlé Health Science (US)
